Author： Gastambide Francois Gilmour Gary
Publisher： Informa Healthcare
ISSN： 1751-2433
Source： Expert Review of Clinical Pharmacology, Vol.5, Iss.6, 2012-11, pp. : 601-603
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Disease-Modifying Therapies in Alzheimer's Disease: How Far Have We Come?
By Hüll Michael Berger Mathias
Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. :
Access to resources
Recommend
Tolcapone guidelines too restrictive?
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
Pharmacogenomics commentary `too optimistic' ?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 383, 2002-01 ,pp. :
Clioquinol: novel agent for Alzheimer's disease?
Inpharma, Vol. 1, Iss. 1353, 2002-01 ,pp. :